Sema4 (NASDAQ:SMFR) Rating Lowered to Hold at Zacks Investment Research
Sema4 (NASDAQ:SMFR – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and […]